• Pharmabiotics, the Conference of D&R (Development & Regulation) 
    February 3–5, 2026 | Brussels
     


    The Pharmabiotics Conference 2026 is not just another scientific meeting. Now celebrating its 10th edition, it has become the Conference of D&R (Development & Regulation): where Discovery is translated into Development, guided by Direction from Regulation, built on Dialogue across disciplines and with authorities, and driven by the Disruption that microbiome science brings to health, food systems, and sustainability.

    What sets this conference apart is its focus on regulatory case studies. With regulatory frameworks still under construction, researchers and developers will share their journeys, real-world experiences that become practical case studies for the entire community. These insights are not only about presenting science, but about turning individual challenges into collective knowledge.

    This unique positioning is clearly reflected in the conference programme, which features sessions on biomarkers and diagnostics, One Health applications, regulatory assessment, and advances in clinical data and emerging technologies. Each theme illustrates how scientific discovery meets regulatory direction to shape the next decade of microbiome innovation.

    Backed by the Pharmabiotic Research Institute (PRI), an independent EU non-profit and recognized stakeholder, the conference ensures that the dialogue between science and regulation carries real weight with regulators, industry, and academia alike.
  • See you in

     

    147

    days

    :

    06

    Hour

    :

    23

    Minutes

    :

    54

    Seconds

  • WHY ATTEND?
     

    ► DiscoveryDevelopment: Translating science into real-world microbiome application or innovation .

    ► Direction: Providing Regulatory compass points in an emerging field where frameworks are still under construction, ensuring discoveries can be applied and advanced within the EU context.

    ► Dialogue: Creating a platform where researchers, regulators, and industry learn from each other’s journeys, accelerating the applicability of microbiome science across disciplines.

    ► Disruption: Showcasing how microbiome science and innovations reshape health, food systems, and sustainability.

    Join us in Brussels this February 2026 to honor the achievements of the past decade and chart the future of microbiome science through development and regulation.
  • Scientific Committee

     
    Héloïse BRETON
    Director, Product management , DNA Genotek 
    Hélène CVEJIC
    Full Professor, University of Novi Sad
    Katja CONRATH
    CSO, MRM Health
    Marco PANE
    R&D Director, Probiotical SPA
    Sylvie BINDA
    R&D Vice President, Lallemand Health Solutions
    Nail NASIR
    CSO, Astel Medica
    Luc STERKMAN
    CEO, Caelus Health
    Ana PALMEIRA
    Professor, University Beira Interior
    Christian ROGHI
    Microbiome Strategy and Innovation Consultant, Big Bold Bridges Consulting
    Sandrine CLAUS
    CEO, Starfish Bioscience
    Julie RODRIGUEZ
    OMICS Project Manager, PRI
    Celine DRUART
    Executive Director, PRI
  • KEY DATES

     
     

    Jan. 2025

     

    Save
    the date

    Febr. 2025

     

    Abstracts submission opening

    June 2025

     

    Registration opening

    3 Nov. 2025

     

    Early bird rate deadline

    15 Nov. 2025

     

    Deadline for abstracts submission

    Dec. 2025

     

    Final programme

    3-5 Febr. 2026

     

    Pharmabiotics 2026

  • Organized by

     
  • The Pharmabiotic Research Institute (PRI) is Europe’s leading association in microbiome regulatory science. “Microbiome regulatory science” refers to the study and development of regulatory frameworks, standards, and guidelines for products, therapies, and interventions that involve or affect the microbiome.

    Established in 2010 as a non-profit organization, the PRI supports the development of microbiome-based innovations by clarifying the regulatory and scientific requirements needed to access the European market. Its mission is to foster dialogue among researchers, product developers, regulators, and policymakers, positioning itself as the central network driving innovation in microbiome science.

    Today, the PRI includes over 70 members from both academia and industry, representing nearly every stage of the microbiome product development chain. Through its unique, collaborative “Share & Learn” approach, the PRI addresses the complex regulatory challenges faced by stakeholders, helping to support and de-risk product development—for the ultimate benefit of citizens and patients.

    “You are an expert in microbiome science. Now it’s time to apply microbiome regulatory science”
     
  • Event PlanneR
    Registration contact
    INSIGHT OUTSIDE
    26 av Jean Kuntzmann - 38330 Montbonnot, France
    Tel : +33 825 595 525 (0,15€/min*)
    Information desk: Monday to Friday
    from 9:00 to 12:00 and 14:00 to 17:00
    (*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 26 Avenue Jean Kuntzmann, 38330 - Montbonnot / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.


    © 2005 - 2025 Insight Outside